Puhr, H. C., Winkler, E. C., & Preusser, M. (2025). Response to letter re: Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022. ESMO open, 10(5), . https://doi.org/10.1016/j.esmoop.2025.105063
Chicago-Zitierstil (17. Ausg.)Puhr, Hannah Christina, Eva C. Winkler, und Matthias Preusser. "Response to Letter Re: Ethnic Origin in Cancer Clinical Trials: Overrated or Understated? A Comprehensive Analysis of Cancer Clinical Trials Leading to FDA and EMA Approvals Between 2020 and 2022." ESMO Open 10, no. 5 (2025). https://doi.org/10.1016/j.esmoop.2025.105063.
MLA-Zitierstil (9. Ausg.)Puhr, Hannah Christina, et al. "Response to Letter Re: Ethnic Origin in Cancer Clinical Trials: Overrated or Understated? A Comprehensive Analysis of Cancer Clinical Trials Leading to FDA and EMA Approvals Between 2020 and 2022." ESMO Open, vol. 10, no. 5, 2025, https://doi.org/10.1016/j.esmoop.2025.105063.